Aflibercept 6.6mg/165microlitres solution for injection pre-filled syringes
NHS hospitals in England used £160,372,397 of indicative cost of Aflibercept 6.6mg/165microlitres solution for injection pre-filled syringes in the 12 months to July 2026, about 0.6% of all hospital medicines spend. That is up 0.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Aflibercept 6.6mg/165microlitres solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Aflibercept 6.6mg/165microlitres solution for injection pre-filled syringes most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Western Sussex Hospitals Nhs Found Trust | £7,976,318 |
| Moorfields Eye Hospital Nhs Ft | £7,563,586 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £6,776,309 |
| Univ Hpls Bristol Nhs Foundation Trust | £5,526,360 |
| York Teaching Hospital Nhs Ft | £4,925,621 |
| Univ Hpl B/Ham Nhs Foundation Trust | £4,684,003 |
| Oxford University Hospitals Nhs Ft | £4,653,158 |
| University Hospitals Dorset Nhs Ft | £4,587,062 |
| Ashford & St Peter's Hospitals Nhs Ft | £4,075,920 |
| Royal Devon & Exeter Nhs Foundation Trst | £4,049,482 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.